ARCHIVES

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

Cancer Care Act Introduced In Senate.

April 18, 2008

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004

Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder

October 20, 1995

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

October 1, 1993

UPCI Puts the Cancer Letter on its Intranet for Employees

May 5, 2000